119 related articles for article (PubMed ID: 9796439)
1. In vivo and in vitro photodynamic studies with benzochlorin iminium salts delivered by a lipid emulsion.
Garbo GM; Fingar VH; Wieman TJ; Noakes EB; Haydon PS; Cerrito PB; Kessel DH; Morgan AR
Photochem Photobiol; 1998 Oct; 68(4):561-8. PubMed ID: 9796439
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy: a new modality for the treatment of cancer.
Hampton JA; Goldblatt PJ; Selman SH
Ann Clin Lab Sci; 1994; 24(3):203-10. PubMed ID: 8048791
[TBL] [Abstract][Full Text] [Related]
3. Copper benzochlorin, a novel photosensitizer for photodynamic therapy: effects on a transplantable urothelial tumor.
Selman SH; Hampton JA; Morgan AR; Keck RW; Balkany AD; Skalkos D
Photochem Photobiol; 1993 Apr; 57(4):681-5. PubMed ID: 8506398
[TBL] [Abstract][Full Text] [Related]
4. Sites of photodamage by the iminium salt of a copper octaethylbenzochlorin.
Kessel D
Photochem Photobiol; 1993 Oct; 58(4):623-6. PubMed ID: 8248337
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
6. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
7. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
8. In vivo stability and photodynamic efficacy of fluorinated bacteriopurpurinimides derived from bacteriochlorophyll-a.
Gryshuk AL; Chen Y; Potter W; Ohulchansky T; Oseroff A; Pandey RK
J Med Chem; 2006 Mar; 49(6):1874-81. PubMed ID: 16539373
[TBL] [Abstract][Full Text] [Related]
9. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.
Hu M; Brasseur N; Yildiz SZ; van Lier JE; Leznoff CC
J Med Chem; 1998 May; 41(11):1789-802. PubMed ID: 9599230
[TBL] [Abstract][Full Text] [Related]
11. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma.
Mosa M; Zitko M; Poucková P
Neoplasma; 1997; 44(3):178-83. PubMed ID: 9372860
[TBL] [Abstract][Full Text] [Related]
12. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
13. Photoproduct formation from a zinc benzochlorin iminium salt detected by fluorescence microscopy.
Amit I; Malik Z; Kessel D
Photochem Photobiol; 1999 Jun; 69(6):700-2. PubMed ID: 10378009
[TBL] [Abstract][Full Text] [Related]
14. A non-laser light source for photodynamic therapy: in vitro effects on normal and malignant cells.
Kashtan H; Haddad R; Greenberg R; Skornick Y; Kaplan O
J Med; 2002; 33(1-4):93-104. PubMed ID: 12939108
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
16. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
[TBL] [Abstract][Full Text] [Related]
17. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
18. Tumor histopathology following new sensitizers: dithiaporphyrin- and sulfoxaporphyrin-mediated photodynamic therapy.
Symonowicz K; Ziólkowski P; Chmielewski P; Latos-Grazynski L; Rabczynski J; Osiecka BJ; Milach J
Anticancer Res; 1999; 19(6B):5385-91. PubMed ID: 10697566
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of four new carbocyanine dyes for photodynamic therapy with lasers.
Lipshutz GS; Castro DJ; Saxton RE; Haugland RP; Soudant J
Laryngoscope; 1994 Aug; 104(8 Pt 1):996-1002. PubMed ID: 8052086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
